Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05189314 · ClinicalTrials.gov registry record

RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study

A clinical trial of Thyroid Nodules, sponsored by Columbia University.

Recruiting
Registry status
100
Enrollment target
1
Study location

NCT05189314 is a study of Thyroid Nodules that is actively recruiting participants, run by Columbia University. The registered enrollment target is 100 participants, below the 150-participant average among 3 other Thyroid Nodules trials with a reported enrollment target (33% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05189314, a study of Thyroid Nodules, is actively recruiting participants, sponsored by Columbia University.

RECRUITING
Registry status
100 participants
Enrollment target
1
Study location

Study Summary

The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their condition.

Conditions Studied

Interventions

  • PROCEDURE Thyroidectomy
  • DEVICE Radiofrequency Ablation

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 100 participants
Start Date 2019-08-30
Est. Completion 2027-08

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT05189314

The ClinicalTrials.gov registry entry for NCT05189314 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 150-participant average among 3 other Thyroid Nodules trials with a reported enrollment target (33% lower). The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Thyroid Nodules appearing as the primary indexed condition, and to 2 interventions - of which Thyroidectomy is the first listed.

NCT05189314 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT05189314 about?

NCT05189314 is a clinical study titled "RFA of Benign Thyroid Nodules: Clinical Outcomes and Quality of Life Study". The purpose of this observational research is to evaluate and compare clinical outcomes after treatment for symptomatic benign multinodular goiter (MNG) patients. This is a data collection study in which we ask participants to give access to information generated before and after treatment of their ...

What is the current status of trial NCT05189314?

This trial is currently recruiting. The enrollment target is 100 participants. The study started on 2019-08-30. Estimated completion is 2027-08.

What conditions does trial NCT05189314 study?

This clinical trial studies the following conditions: Thyroid Nodules.

What interventions are being tested in trial NCT05189314?

The interventions under investigation include: Thyroidectomy (PROCEDURE), Radiofrequency Ablation (DEVICE).

Who is sponsoring clinical trial NCT05189314?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05189314 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Thyroid Nodules

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.